-
Mashup Score: 5Il tumore alla prostata - TG4 Video | Mediaset Infinity - 1 month(s) ago
In studio Filippo Alongi, Professore e Direttore di radioterapia Irccs, Ospedale Sacro Cuore Negrar di Verona.
Source: mediasetinfinity.mediaset.itCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 219
This phase 1 study aimed to assess the safety and feasibility of SABR therapy delivery to all sites of polymetastatic disease (>10 metastases).
Source: www.redjournal.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 6Radiation Therapy for Cancer Treatment - Targeting Cancer - 3 month(s) ago
Radiation therapy (also known as radiotherapy) is a safe and effective treatment option that would benefit 1 in 2 people with cancer.
Source: www.targetingcancer.com.auCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 6Reminder to register! - 5 month(s) ago
The SIGA Workshop & COGNO ASM will be held at The Langham, a fantastic venue on the banks of the Yarra River. Onsite accommodation is available, see below
Source: shoutout.wix.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Radiation Therapy for Cancer Treatment - Targeting Cancer - 6 month(s) ago
Radiation therapy (also known as radiotherapy) is a safe and effective treatment option that would benefit 1 in 2 people with cancer.
Source: www.targetingcancer.com.auCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Radiation Therapy for Cancer Treatment - Targeting Cancer - 6 month(s) ago
Radiation therapy (also known as radiotherapy) is a safe and effective treatment option that would benefit 1 in 2 people with cancer.
Source: www.targetingcancer.com.auCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 15
At diagnosis, <1% of patients with non-small cell lung cancer (NSCLC) have synchronous solitary brain metastasis (SSBM). In prior cohorts without 18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) staging, definitive treatment to intracranial and intrathoracic disease showed a 5-year overall survival (OS) of 11–21%. We investigated the long-term survival outcomes for patients with SSBM NSCLC, diagnosed in the FDG-PET/CT era and treated definitively with local therapies to both intracranial and intrathoracic sites of disease.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 68Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval - 9 month(s) ago
This study aims to determine whether cancer drugs granted accelerated approval from the US Food and Drug Administration ultimately demonstrate clinical benefit and to evaluate the basis of conversion to regular approval.
Source: jamanetwork.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 65Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval - 9 month(s) ago
This study aims to determine whether cancer drugs granted accelerated approval from the US Food and Drug Administration ultimately demonstrate clinical benefit and to evaluate the basis of conversion to regular approval.
Source: jamanetwork.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 80CONGRESO SOCHIRA 2024 | SOCHIRA - 9 month(s) ago
Con mucho agrado anunciamos la “XVIII Congreso Sociedad Chilena de Radioterapia Oncologica” a desarrollarse entre los d í as 11 y 14 de Abril 2024 en Hotel Cumbres de San Pedro de Atacama, Chile. La jornada contar á con la participaci ó n de especialistas en diversas á reas de inter é s a nivel nacional e internacional, orientado principalmente a m é dicos onc ó logos radioterapeutas, tecn ó logos m é dicos, f í sicos m é dicos, y otros profesionales especialistas que trabajan en radioterapia, resultando
Source: www.sochira.clCategories: General Medicine News, Oncologists2Tweet
RT @alongi_filippo: Radioterapia e tumore della prostata oggi su rete 4 https://t.co/89PdINitqK